Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Saudi Arabia

 

Exploring Saudi Arabia’s “completely different universe” for healthcare investors, with Youssef Haidar of Nexus Gulf

This interview features in the HBI 2025: Disruptive Innovation: Investing in Healthcare Transformation Conference Report, which was shared with conference delegates, and is available to HBI Deals and Insights and Intelligence members. Saudi Arabia’s rapidly developing private healthcare sector offers significant opportunities for international providers prepared to enter the country with the right partnerships, according […]
May 21, 2025

Fakeeh Care Group and Fosun Pharma sign strategic partnership

Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
May 1, 2025

‘Saudization’ kickstarts in Saudi Arabia’s healthcare sector

The first phase of ‘Saudization’ in Saudi Arabia’s healthcare sector is now underway, effective from 17 April. Saudization is a government policy to increase the number of Saudi nationals employed and reduce the reliance on expats in the workforce. 
April 24, 2025

FREE BLOG Blog: To Paris, and beyond!

There’s a palpable sense of purpose within the HBI team, who I can report are relishing the prospect of hosting the industry we serve in Paris for the very first time later this month. If you’re reading this and haven’t yet got your ticket, it’s not too late to book now. Please join us for […]
March 6, 2025

Saudi Arabia’s SMC Hospitals eyes IPO

Saudi Arabian healthcare group SMC Hospitals is planning an initial public offering in Riyadh, as part of a trend of healthcare firms going public in the kingdom.
February 27, 2025

Exploring the GCC’s prospective $11 billion GLP-1 RA market — ‘a unique opportunity to lead in this space’

Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?
November 8, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us